Bricks n' Mortar Update: Pharmaceutical-Biotech Sector Plans 199 New Facilities with $20 Billion in Capital Investment Potential
Attachment: newbuild pharma
SUGAR LAND--May 3, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Scattered throughout North America are 199 reported new-facility builds in the Pharmaceutical-Biotech Industry, according to Industrial Info's Pharmaceutical-Biotech Online Database. The sites represent a potential total capital investment of just over $20 billion, which translates to a per-site average of about $100 million. The "potential" investment for each site includes initial construction, as well as any reported planned future expansions and subsequent phases.
Within this article: Describes Novo Nordisk AS's (NYSE:NVO) APIs plant project in Clayton, North Carolina.
